Full phase 2 data of Lilly's donanemab for Alzheimer's offers mixed bag
14 March 2021 - 1:20AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Apr 2024 to May 2024
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From May 2023 to May 2024